Clinical Trial Update: A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for BMS-986504 in pre-treated advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BMS-986504

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: RECRUITING